Companies/US/ITRMF

ITERUM THERAPEUTICS PLC

Ownership & governance

Executives 3Directors 4Avg age 63Avg tenure 4.7y
David Kelly
Chairman
Age 65Since 2025-03-09Profile →

Executives3

Tom Loughman
Chief Tech/Sci/R&D Officer
—Since 2016-09-30
Steven Aronin
Chief Tech/Sci/R&D Officer
—Since 2017-06-30
Christine Coyne
Corporate Officer/Principal
Age 58Since 2025-06-29

Board of directors4

David Kelly
Chairman
Age 65Since 2025-03-09
Michael Dunne
Director/Board Member
Age 67Since 2020-12-21
Beth Hecht
Director/Board Member
Age 62Since 2021-03-11
Joe Whalen
Director/Board Member
—Since 2025-03-09

Shareholders5

NameStakeShares
HRT Financial LP
1.685 %
890,083
Abante Asesores Gestión SGIIC SA
0.5011 %
264,766
Michael Dunne
0.4561 %
241,001
CapFinancial Partners LLC
0.2623 %
138,600
Corey Fishman
0.2594 %
137,062

Catalog · 2026-07-09

Registry officers7

NameRoleSinceShares
David KellyChairman2025-03-09-
Steven AroninChief Tech/Sci/R&D Officer2017-06-30-
Tom LoughmanChief Tech/Sci/R&D Officer2016-09-30-
Beth HechtDirector/Board Member2021-03-11-
Joe WhalenDirector/Board Member2025-03-09-
Michael DunneDirector/Board Member2020-12-21-
Christine CoyneCorporate Officer/Principal2025-06-29-

Registry · as of 2026-07-09

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus none

Broker actions1

FirmActionToTargetDate
HC Wainwright & Co.DowngradeNeutral—2026-03-30

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers